NCT07120789 Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension
| NCT ID | NCT07120789 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Sao Paulo General Hospital |
| Condition | Pulmonary Arterial Hypertension (PAH) |
| Study Type | INTERVENTIONAL |
| Enrollment | 215 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 215 participants in total. It began in 2025-09-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This methodological study aims to develop and validate a questionnaire named for the Assessment of Patient Knowledge in Pulmonary Arterial Hypertension. The study will be conducted in four phases: (1) questionnaire development based on guidelines and literature; (2) content validation by expert judges; (3) semantic validation with patients; and (4) psychometric testing in a sample of up to 200 patients with confirmed pulmonary arterial hypertension (PAH). In addition to validation, the study will collect clinical and functional data from medical records, including risk stratification using the COMPERA 2.0 method The final instrument is expected to support patient education strategies and contribute to improved clinical management of PAH.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years or older * Confirmed diagnosis of Group 1 Pulmonary Arterial Hypertension (PAH) * Ability to read and understand the questionnaire language * Provided informed consent to participate in the study * For expert judges (content validation phase): professionals with recognized expertise in pulmonary hypertension, with academic or clinical experience in the field Exclusion Criteria: * Cognitive, visual, or auditory impairments that hinder questionnaire comprehension * Refusal to participate or withdrawal of informed consent * Inability to complete the questionnaire due to clinical instability
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07120789 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Arterial Hypertension (PAH). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07120789 currently recruiting?
Yes, NCT07120789 is actively recruiting participants. Contact the research team at caio.cesar@hc.fm.usp.br for enrollment information.
Where is the NCT07120789 trial being conducted?
This trial is being conducted at São Paulo, Brazil.
Who is sponsoring the NCT07120789 clinical trial?
NCT07120789 is sponsored by University of Sao Paulo General Hospital. The trial plans to enroll 215 participants.